bm 13505 has been researched along with Disease Models, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Butenas, ALE; Copp, SW; Felice, KP; Kleweno, TE; Matney, JE; Rollins, KS; Williams, AC | 1 |
| Kaufman, MP; Leal, AK; McCord, JL; Tsuchimochi, H | 1 |
| Bernheim, J; Green, J; Podjarny, E; Pomeranz, A; Rathaus, M | 1 |
| Higo, K; Karasawa, A; Shirakura, S; Takeda, M | 1 |
| Higo, K; Karasawa, A | 1 |
| Czymek, R; Ermert, L; Grimminger, F; Krämer, HJ; Rosseau, S; Schütte, H; Seeger, W; Walmrath, D | 1 |
| Arakida, Y; Honda, K; Miyata, K; Ohga, K; Suwa, K; Yamada, T; Yokota, M | 1 |
| Mihatsch, MJ; Schoeppe, W; Stahl, RA; Thaiss, F | 1 |
| Helmchen, U; Schoeppe, W; Stahl, RA; Thaiss, F; Wenzel, U | 1 |
| Hartig, F; Metz, J; Pill, J; Schmelz, A; Stegmeier, KH; Wolf, O | 1 |
| Al-Wathiqui, MH; Brooks, HL; Hartman, JC; Warltier, DC | 1 |
| Aoki, N; Lefer, AM | 1 |
13 other study(ies) available for bm 13505 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Thromboxane A
Topics: Animals; Arterial Pressure; Disease Models, Animal; Male; Mechanoreceptors; Mechanotransduction, Cellular; Muscle Contraction; Muscle, Skeletal; Peripheral Arterial Disease; Phenylacetates; Rats, Sprague-Dawley; Receptors, Prostaglandin E, EP4 Subtype; Receptors, Thromboxane A2, Prostaglandin H2; Reflex; Sulfonamides; Time Factors | 2020 |
Blockade of the TP receptor attenuates the exercise pressor reflex in decerebrated rats with chronic femoral artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Baroreflex; Blood Pressure; Chronic Disease; Decerebrate State; Disease Models, Animal; Femoral Artery; Heart Rate; Injections, Intra-Arterial; Injections, Intravenous; Ligation; Male; Mechanoreceptors; Muscle Contraction; Muscle, Skeletal; Phenylacetates; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Sulfonamides; Thromboxanes | 2011 |
Adriamycin-related hypertension in pregnant rats: response to a thromboxane receptor antagonist.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Disease Models, Animal; Doxorubicin; Female; Hypertension; Phenylacetates; Pregnancy; Pregnancy Complications, Cardiovascular; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxanes | 1995 |
Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Benzimidazoles; Benzoxepins; Blood Coagulation; Blood Platelets; Disease Models, Animal; Erythrocyte Count; Femoral Artery; Guinea Pigs; Lauric Acids; Male; Phenylacetates; Platelet Count; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxanes; Ticlopidine | 1994 |
Inhibitory effect of KW-3635, a new thromboxane A2-receptor antagonist, on arterial thrombosis in guinea pigs.
Topics: Animals; Arachidonic Acid; Aspirin; Benzimidazoles; Benzoxepins; Collagen; Disease Models, Animal; Femoral Artery; Guinea Pigs; Male; Phenylacetates; Platelet Aggregation; Sulfonamides; Thrombosis; Thromboxane A2 | 1993 |
Synergism between endotoxin priming and exotoxin challenge in provoking severe vascular leakage in rabbit lungs.
Topics: Animals; Bacteremia; Bacterial Proteins; Capillary Permeability; Disease Models, Animal; Drug Synergism; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extravascular Lung Water; Female; Hemolysin Proteins; In Vitro Techniques; Lipopolysaccharides; Male; Phenylacetates; Pulmonary Circulation; Rabbits; Receptors, Thromboxane; Respiratory Insufficiency; Sulfonamides | 1997 |
Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs.
Topics: Administration, Oral; Animals; Asthma; Chromones; Disease Models, Animal; Guinea Pigs; Immunization, Passive; Leukotriene Antagonists; Leukotrienes; Male; Membrane Proteins; Phenylacetates; Receptors, Leukotriene; Receptors, Thromboxane; Serum Albumin, Bovine; Sulfonamides; Tetrazoles; Thiazoles; Thromboxane A2; Thromboxane B2 | 1999 |
Thromboxane mediates glomerular haemodynamics in a model of chronic glomerular disease.
Topics: Animals; Dietary Proteins; Disease Models, Animal; Eicosanoids; Glomerular Filtration Rate; Glomerulonephritis; Indomethacin; Kidney Glomerulus; Phenylacetates; Rats; Renal Circulation; Sulfonamides; Thromboxanes | 1992 |
A rat model of progressive chronic glomerular sclerosis: the role of thromboxane inhibition.
Topics: Albuminuria; Animals; Antibodies; Disease Models, Animal; Eicosanoids; Glomerulosclerosis, Focal Segmental; Imidazoles; Male; Phenylacetates; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane-A Synthase; Thromboxanes | 1992 |
Atherosclerosis in the aorta of hypercholesterolemic rabbits and the influence of daltroban.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Hypercholesterolemia; Male; Phenylacetates; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes | 1991 |
Induction of cyclic flow reduction in the coronary, carotid, and femoral arteries of conscious, chronically instrumented dogs. A model for investigating the role of platelets in severely constricted arteries.
Topics: Animals; Blood Platelets; Blood Pressure; Carotid Arteries; Coronary Circulation; Disease Models, Animal; Dogs; Female; Femoral Artery; In Vitro Techniques; Male; Phenylacetates; Regional Blood Flow; Sulfonamides; Thromboxanes | 1988 |
Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
Topics: Animals; Blood Pressure; Cathepsin D; Disease Models, Animal; Hematocrit; Male; Mesenteric Vascular Occlusion; Myocardial Depressant Factor; Nitrogen; Phenylacetates; Rats; Rats, Inbred Strains; Shock; Splanchnic Circulation; Sulfonamides; Thromboxane A2 | 1988 |